PPI-1019

CAS No. 290828-45-4

PPI-1019( —— )

Catalog No. M34384 CAS No. 290828-45-4

PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 787 In Stock
10MG 1074 In Stock
25MG 1511 In Stock
50MG 1841 In Stock
100MG 2325 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PPI-1019
  • Note
    Research use only, not for human use.
  • Brief Description
    PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).
  • Description
    PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    Beta Amyloid
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    290828-45-4
  • Formula Weight
    650.85
  • Molecular Formula
    C36H54N6O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [C@@H](CC1=CC=CC=C1)(C(N[C@H](CC2=CC=CC=C2)C(N[C@H](CC(C)C)C(N)=O)=O)=O)NC([C@H](NC([C@@H](CC(C)C)NC)=O)C(C)C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • RAGE antagonist pept...

    Receptor for advanced glycation end products (RAGE) antagonist. Blocks S100P, S100A4 and HMGB-1 mediated RAGE activation in vitro and in vivo. Inhibits growth and metastasis of rat glioma tumors. Reduces cell growth and RAGE-mediated NF-κB activity in human PDAC cell lines. Inhibits effects of TDI exposure in BALB/c mice.

  • β-Amyloid 31-35

    β-Amyloid (31-35) is the shortest sequence of native Amyloid-β peptide that retains neurotoxic activity. This synthetic peptide consists of amino acids 31 to 35 of beta amyloid protein.

  • β-Amyloid 1-9

    This is an N-terminal fragment of beta amyloid. It consists of amino acid residues 1 to 9. Truncated beta amyloid peptide (10-40) still forms amyloid fibrils and shows fibril polymorphism.